Arkolith/Insider Trading/COLL/Form 4

Dreyer Scott

EVP & Chief Commercial OfficerCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Dec 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$848K
Net Open-Market Flow
-$848K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2025Sell(S)11K$47.89$533K110K
Dec 8, 2025Sell(S)6K$48.66$315K104K
Dec 8, 2025Option exercise(M)18K$15.90$280K121K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 8, 2025Option exercise(M)18K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001746251-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML